Navigating the Complex Landscape of COVID-19 Vaccine Hesitancy in Asia: Identifying Key Determinants and Strategies for Improvement
DOI:
https://doi.org/10.53819/81018102t4134Abstract
Most LMICs have been slow to receive and distribute vaccines, which are much more available in high-income countries, prompting critiques of global vaccine inequity, which were exacerbated with the distribution of so-called booster shots in high-income countries in the autumn of 2021. Access issues, coupled with vaccine hesitancy, can have catastrophic effects. Vaccination against the novel coronavirus is one of the most effective strategies for combating the global Coronavirus disease (COVID-19) pandemic. However, vaccine hesitancy has emerged as a major obstacle in several regions of the world, including Asia. The COVID-19 pandemic has necessitated the rapid development and distribution of vaccines worldwide. However, vaccine hesitancy, particularly in Asia, poses a significant challenge to achieving herd immunity and controlling the pandemic. This study aims to identify the key determinants of COVID-19 vaccine hesitancy in Asian populations and develop targeted strategies to improve vaccination uptake. A comprehensive review of literature from 2019 to 2020 was conducted, focusing on sociocultural, political, and healthcare system factors that contribute to vaccine hesitancy in the region. Findings reveal that cultural and religious beliefs, misinformation and distrust in government and healthcare systems, and logistical and accessibility issues significantly impact vaccine uptake. To address these challenges, the study proposes strategies such as engaging with community leaders, improving communication, building public trust, and addressing logistical and accessibility barriers. By comprehensively understanding and addressing the determinants of COVID-19 vaccine hesitancy in Asia, the public health community can navigate the complex landscape and facilitate higher vaccination rates, ultimately contributing to the global control of the COVID-19 pandemic.
Keywords: COVID-19 vaccine, Vaccine hesitancy, Determinants, Strategies for improvement, Asia
References
Bono, S. A., Faria de Moura Villela, E., Siau, C. S., Chen, W. S., Pengpid, S., Hasan, M. T., ... & Colebunders, R. (2021). Factors affecting COVID-19 vaccine acceptance: an international survey among low-and middle-income countries. Vaccines, 9(5), 515.
Caserotti, M., Girardi, P., Rubaltelli, E., Tasso, A., Lotto, L., & Gavaruzzi, T. (2021). Associations of COVID-19 risk perception with vaccine hesitancy over time for Italian residents. Social science & medicine, 272, 113688.
Chou, W. S., Budenz, A., & Smith, B. (2020). Addressing vaccine hesitancy and misinformation in the age of COVID-19: a content analysis of global health organizations' social media communication. Human Vaccines & Immunotherapeutics, 1-9.
Chou, W. S., Budenz, A., & Smith, B. (2020). Addressing vaccine hesitancy and misinformation in the age of COVID-19: a content analysis of global health organizations' social media communication. Human Vaccines & Immunotherapeutics, 1-9.
Deml, M. J., & Githaiga, J. N. (2022). Determinants of COVID-19 vaccine hesitancy and uptake in sub-Saharan Asia: a scoping review. BMJ open, 12(11), e066615.
Engelbrecht, M., Heunis, C., & Kigozi, G. (2022). COVID-19 Vaccine Hesitancy in South Asia: Lessons for Future Pandemics. International Journal of Environmental Research and Public Health, 19(11), 6694.
Erchick, D. J., Gupta, M., Blunt, M., Bansal, A., Sauer, M., Gerste, A., ... & Limaye, R. J. (2022). Understanding determinants of vaccine hesitancy and acceptance in India: A qualitative study of government officials and civil society stakeholders. PloS one, 17(6), e0269606.
Ergün, A., Bekar, A., Aras, B., Dere, C., Tekneci, D., Sarıçiçek, G., ... & Aslan, D. (2022). Determination of Novel Coronavirus Disease (COVID-19) Vaccine Hesitancy Using a Systematic Review Approach Based on the Scientific Articles in PubMed Database. Turkish Thoracic Journal, 23(1), 70-84.
Fisk, R. J. (2021). Barriers to vaccination for coronavirus disease 2019 (COVID-19) control: experience from the United States. Global Health Journal, 5(1), 51-55.
Harapan, H., Wagner, A. L., Yufika, A., Winardi, W., Anwar, S., Gan, A. K., ... & Mudatsir, M. (2020). Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia. Frontiers in Public Health, 8, 381.
Kenzig, M. J., & Mumford, N. S. (2022). Theoretical Considerations for Communication Campaigns to Address Vaccine Hesitancy. Health Promotion Practice, 23(1), 46-50.
Larson, H. J., Gakidou, E., & Murray, C. J. (2022). The vaccine-hesitant moment. New England Journal of Medicine, 387(1), 58-65.
Lazarus, J. V., Ratzan, S. C., Palayew, A., Gostin, L. O., Larson, H. J., Rabin, K., ... & El-Mohandes, A. (2021). A global survey of potential acceptance of a COVID-19 vaccine. Nature medicine, 27(2), 225-228.
Leigh, J. P., Moss, S. J., White, T. M., Picchio, C. A., Rabin, K. H., Ratzan, S. C., ... & Lazarus, J. V. (2022). Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries. Vaccine.
Li, L., Wood, C. E., & Kostkova, P. (2022). Vaccine hesitancy and behavior change theory-based social media interventions: a systematic review. Translational behavioral medicine, 12(2), 243-272.
Li, M., Luo, Y., Watson, R., Zheng, Y., Ren, J., Tang, J., & Chen, Y. (2021). Healthcare workers’(HCWs) attitudes and related factors towards COVID-19 vaccination: A rapid systematic review. Postgraduate medical journal.
Loomba, S., de Figueiredo, A., Piatek, S. J., de Graaf, K., & Larson, H. J. (2021). Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nature human behaviour, 5(3), 337-348.
Lurie, N., Saville, M., Hatchett, R., & Halton, J. (2020). Developing Covid-19 Vaccines at Pandemic Speed. New England Journal of Medicine, 382(21), 1969-1973.
Sallam, M. (2021). COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines, 9(2), 160.
Wilson, S. L., & Wiysonge, C. (2020). Social media and vaccine hesitancy. BMJ global health, 5(10), e004206.
Wong, L. P., Alias, H., Wong, P. F., Lee, H. Y., & AbuBakar, S. (2019). The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Human Vaccines & Immunotherapeutics, 1-11.
Wong, L. P., Alias, H., Wong, P. F., Lee, H. Y., & AbuBakar, S. (2019). The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Human Vaccines & Immunotherapeutics, 1-11.
World Health Organization. (2019). WHO global report on traditional and complementary medicine 2019. World Health Organization.
World Health Organization. (2022). COVID-19 weekly epidemiological update, edition 115, 26 October 2022.
World Health Organization. (2022). WHO consolidated guidelines on tuberculosis. Module 5: management of tuberculosis in children and adolescents. World Health Organization.
World Health Organization. (2022). World malaria report 2022. World Health Organization.
Xiao, X., & Wong, R. M. (2020). Vaccine hesitancy and perceived behavioral control: A meta-analysis. Vaccine, 38(33), 5131-5138.
Yang, R., Penders, B., & Horstman, K. (2019). Addressing vaccine hesitancy in China: a scoping review of Chinese scholarship. Vaccines, 8(1), 2.
Zak, E. (2021). History of Vaccine Misinformation: A Timeline (Doctoral dissertation, University of Iowa).
